1. Home
  2. ERNA vs DHAI Comparison

ERNA vs DHAI Comparison

Compare ERNA & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERNA
  • DHAI
  • Stock Information
  • Founded
  • ERNA 2018
  • DHAI 2007
  • Country
  • ERNA United States
  • DHAI United States
  • Employees
  • ERNA N/A
  • DHAI N/A
  • Industry
  • ERNA Biotechnology: Pharmaceutical Preparations
  • DHAI
  • Sector
  • ERNA Health Care
  • DHAI
  • Exchange
  • ERNA Nasdaq
  • DHAI NYSE
  • Market Cap
  • ERNA 13.5M
  • DHAI 11.6M
  • IPO Year
  • ERNA N/A
  • DHAI N/A
  • Fundamental
  • Price
  • ERNA $1.92
  • DHAI $0.28
  • Analyst Decision
  • ERNA
  • DHAI
  • Analyst Count
  • ERNA 0
  • DHAI 0
  • Target Price
  • ERNA N/A
  • DHAI N/A
  • AVG Volume (30 Days)
  • ERNA 53.7K
  • DHAI 2.8M
  • Earning Date
  • ERNA 08-12-2025
  • DHAI 08-18-2025
  • Dividend Yield
  • ERNA N/A
  • DHAI N/A
  • EPS Growth
  • ERNA N/A
  • DHAI N/A
  • EPS
  • ERNA N/A
  • DHAI N/A
  • Revenue
  • ERNA $535,000.00
  • DHAI $69,573,000.00
  • Revenue This Year
  • ERNA N/A
  • DHAI N/A
  • Revenue Next Year
  • ERNA N/A
  • DHAI N/A
  • P/E Ratio
  • ERNA N/A
  • DHAI N/A
  • Revenue Growth
  • ERNA 365.22
  • DHAI 5.40
  • 52 Week Low
  • ERNA $1.75
  • DHAI $0.12
  • 52 Week High
  • ERNA $32.40
  • DHAI $3.32
  • Technical
  • Relative Strength Index (RSI)
  • ERNA 39.97
  • DHAI 55.41
  • Support Level
  • ERNA $1.91
  • DHAI $0.24
  • Resistance Level
  • ERNA $2.57
  • DHAI $0.31
  • Average True Range (ATR)
  • ERNA 0.18
  • DHAI 0.02
  • MACD
  • ERNA 0.04
  • DHAI 0.00
  • Stochastic Oscillator
  • ERNA 19.77
  • DHAI 59.00

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

About DHAI DIH HOLDINGS US INC

DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.

Share on Social Networks: